• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Medicare reform law carries hidden costs

Author(s):

Bob Gatty

While Medicare recipients now have some help in covering the cost of prescription drugs, the new Medicare reform law passed by Congress carries some hidden costs that may result in difficulties in obtaining care for some patients. This applies, in particular, to physicians who administer drugs in their offices.

Related Videos
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
Related Content
Conference Recap: Fall Clinical 2024
Published: October 30th 2024 | Updated: October 30th 2024

Conference Recap: Fall Clinical 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

New TRoSA Scale Standardizes Telangiectasia Severity in Rosacea
October 30th 2024

New TRoSA Scale Standardizes Telangiectasia Severity in Rosacea

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Uncovering Systemic Corticosteroid Use and Updates on Long-Term Management Benefits of Upadacitinib in AD
October 30th 2024

Uncovering Systemic Corticosteroid Use and Updates on Long-Term Management Benefits of Upadacitinib in AD

Impact of Malignant Melanoma on Employment and Work Ability
October 30th 2024

Impact of Malignant Melanoma on Employment and Work Ability

© 2024 MJH Life Sciences

All rights reserved.